Landscapes / Companies

Livzon Pharmaceutical Group Inc. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved in South Korea
Next date
None yet
 
Drugs
2
in active trials · 5 in all
Trials
2 active
11 since 2021

Drugs2

DrugHow it worksPartnerStageNext dateDetails
—
Approved in South Korea —
—
Phase 2 —

About

No active trial
LZM012, Recombinant SARS-CoV-2 Beta Variant Fusion Protein Vaccine/Recombinant SARS-CoV-2 Delta Variant Fusion Protein Vaccine, Recombinant SARS-CoV-2 Fusion Protein Vaccine
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 20 Nov 2026 Industry-sponsored drug trials since 2021

Follow Livzon Pharmaceutical Group Inc.

Following is part of Solo: you see every change to Livzon Pharmaceutical Group Inc. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in